Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.2/5
Shanghai Junshi Biosciences (1877 HK)
Watchlist
229
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
14 Mar 2025 08:30
Date Of Board Meeting
Attachment
Exchange Announcement •
27 Feb 2025 10:58
Inside Information - 2024 Preliminary Results
Attachment
Exchange Announcement •
05 Feb 2025 12:30
Voluntary Announcement - Js213 Received The Notice Of Approval For Clinical Trial
Attachment
Exchange Announcement •
20 Jan 2025 12:46
Voluntary Announcement - Entering Into The Distribution And Marketing Agreement With Leo Pharma
Attachment
Exchange Announcement •
17 Jan 2025 11:52
Voluntary Announcement - Approval By The Tga For Marketing Of Toripalimab
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0
x